{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:59:09Z","timestamp":1789520349783,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Robert Koch-Institut"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Mit Virushepatitis\u00a0A bis\u00a0E werden verschiedene infekti\u00f6se Entz\u00fcndungen des Leberparenchyms bezeichnet, die durch die Hepatitisviren\u00a0A bis\u00a0E (HAV, HBV, HCV, HDV und HEV) ausgel\u00f6st werden. Zwar \u00e4hneln sich die Krankheitsbilder, die Erreger geh\u00f6ren jedoch zu verschiedenen Virusfamilien und unterscheiden sich bez\u00fcglich der Pathogenese, der \u00dcbertragungswege, des klinischen Verlaufs und der Pr\u00e4ventions- und Therapiem\u00f6glichkeiten. In Deutschland besteht eine namentliche Meldepflicht nach Infektionsschutzgesetz (IfSG) f\u00fcr den direkten oder indirekten Nachweis und f\u00fcr Verdacht, Erkrankung und Tod. Die Daten werden an das Robert Koch-Institut \u00fcbermittelt.<\/jats:p><jats:p>In diesem Beitrag wird die Epidemiologie der Hepatitiden\u00a0A bis\u00a0E anhand publizierter Studien und Meldedaten beschrieben und es werden aktuelle Herausforderungen und Pr\u00e4ventionsans\u00e4tze aufgezeigt. Letztere bestehen insbesondere in der verbesserten Umsetzung bereits bestehender Impfempfehlungen (Hepatitis\u00a0A und\u00a0B), dem verbesserten Zugang zu Pr\u00e4vention, Testung und Versorgung, einschlie\u00dflich Therapie mit antiviralen Medikamenten (Hepatitis\u00a0B, C\u00a0und\u00a0D), und der Erkennung und Verhinderung lebensmittelbedingter Infektionen und Ausbr\u00fcche und Verbesserungen auf dem Gebiet der Lebensmittelsicherheit (Hepatitis\u00a0A und\u00a0E).<\/jats:p>","DOI":"10.1007\/s00103-021-03478-8","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T09:03:32Z","timestamp":1642151012000},"page":"149-158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Epidemiologie der Virushepatitiden\u00a0A bis\u00a0E in Deutschland","Epidemiology of viral hepatitis\u00a0A to\u00a0E in Germany"],"prefix":"10.1007","volume":"65","author":[{"given":"Sandra","family":"Dudareva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-Thomas","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Offergeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyde","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Enkelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"issue":"22","key":"3478_CR1","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJM198005293022203","volume":"302","author":"SC Hadler","year":"1980","unstructured":"Hadler\u00a0SC, Webster\u00a0HM, Erben\u00a0JJ, Swanson\u00a0JE, Maynard\u00a0JE (1980) Hepatitis A in day-care centers. A community-wide assessment. N\u00a0Engl J Med 302(22):1222\u20131227","journal-title":"N Engl J Med"},{"issue":"1","key":"3478_CR2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00005792-199201000-00002","volume":"71","author":"M Glikson","year":"1992","unstructured":"Glikson\u00a0M, Galun\u00a0E, Oren\u00a0R, Tur-Kaspa\u00a0R, Shouval\u00a0D (1992) Relapsing hepatitis A. Review of 14\u00a0cases and literature survey. Medicine 71(1):14\u201323","journal-title":"Medicine"},{"issue":"3","key":"3478_CR3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12560-018-9349-1","volume":"10","author":"N Cook","year":"2018","unstructured":"Cook\u00a0N, Bertrand\u00a0I, Gantzer\u00a0C, Pinto\u00a0RM, Bosch\u00a0A (2018) Persistence of hepatitis A virus in fresh produce and production environments, and the effect of disinfection procedures: a review. Food Environ Virol 10(3):253\u2013262","journal-title":"Food Environ Virol"},{"issue":"34","key":"3478_CR4","first-page":"1","volume":"2020","author":"St\u00e4ndige Impfkommission","year":"2020","unstructured":"St\u00e4ndige Impfkommission (2020) Empfehlungen der St\u00e4ndigen Impfkommission beim Robert Koch-Institut \u2013 2020\/2021. Epidemiol Bull 2020(34):1\u201368","journal-title":"Epidemiol Bull"},{"issue":"1","key":"3478_CR5","doi-asserted-by":"crossref","first-page":"16696","DOI":"10.1038\/s41598-018-34927-1","volume":"8","author":"K Michaelis","year":"2018","unstructured":"Michaelis\u00a0K, Poethko-M\u00fcller\u00a0C, Kuhnert\u00a0R, Stark\u00a0K, Faber\u00a0M (2018) Hepatitis A virus infections, immunisations and demographic determinants in children and adolescents, Germany. Sci Rep 8(1):16696","journal-title":"Sci Rep"},{"issue":"5","key":"3478_CR6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00103-013-1673-x","volume":"56","author":"C Poethko-M\u00fcller","year":"2013","unstructured":"Poethko-M\u00fcller\u00a0C, Zimmermann\u00a0R, Hamouda\u00a0O, Faber\u00a0M, Stark\u00a0K, Ross\u00a0RS et al (2013) Die Seroepidemiologie der Hepatitis\u00a0A, B und C in Deutschland. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56(5):707\u2013715","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"5\u20136","key":"3478_CR7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00103-013-1693-6","volume":"56","author":"C Poethko-M\u00fcller","year":"2013","unstructured":"Poethko-M\u00fcller\u00a0C, Schmitz\u00a0R (2013) Impfstatus von Erwachsenen in Deutschland. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56(5\u20136):845\u2013857","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3478_CR8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijid.2020.11.133","volume":"103","author":"R Zimmermann","year":"2021","unstructured":"Zimmermann\u00a0R, Faber\u00a0M, Dudareva\u00a0S, Ingiliz\u00a0P, Jessen\u00a0H, Koch\u00a0J et\u00a0al (2021) Hepatitis A outbreak among MSM in Berlin due to low vaccination coverage: epidemiology, management, and successful interventions. Int J Infect Dis 103:146\u2013153","journal-title":"Int J Infect Dis"},{"issue":"4","key":"3478_CR9","first-page":"e26","volume":"6","author":"K Michaelis","year":"2017","unstructured":"Michaelis\u00a0K, Wenzel\u00a0JJ, Stark\u00a0K, Faber\u00a0M (2017) Hepatitis A virus infections and outbreaks in asylum seekers arriving to Germany, September 2015 to March 2016. Emerg Microbes Infect 6(4):e26","journal-title":"Emerg Microbes Infect"},{"issue":"33","key":"3478_CR10","doi-asserted-by":"crossref","first-page":"1700641","DOI":"10.2807\/1560-7917.ES.2018.23.33.1700641","volume":"23","author":"P Ndumbi","year":"2018","unstructured":"Ndumbi\u00a0P, Freidl\u00a0GS, Williams\u00a0CJ, Mardh\u00a0O, Varela\u00a0C, Avellon\u00a0A et\u00a0al (2018) Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area, June 2016 to May 2017. Euro Surveill 23(33):1700641","journal-title":"Euro Surveill"},{"issue":"27","key":"3478_CR11","doi-asserted-by":"crossref","first-page":"1800329","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800329","volume":"23","author":"M Gassowski","year":"2018","unstructured":"Gassowski\u00a0M, Michaelis\u00a0K, Wenzel\u00a0JJ, Faber\u00a0M, Figoni\u00a0J, Mouna\u00a0L et al (2018) Two concurrent outbreaks of hepatitis A highlight the risk of infection for non-immune travellers to Morocco, January to June 2018. Euro Surveill 23(27):1800329","journal-title":"Euro Surveill"},{"issue":"37","key":"3478_CR12","doi-asserted-by":"crossref","first-page":"1900670","DOI":"10.2807\/1560-7917.ES.2020.25.37.1900670","volume":"25","author":"C Ruscher","year":"2020","unstructured":"Ruscher\u00a0C, Faber\u00a0M, Werber\u00a0D, Stark\u00a0K, Bitzegeio\u00a0J, Michaelis\u00a0K et\u00a0al (2020) Resurgence of an international hepatitis A outbreak linked to imported frozen strawberries, Germany, 2018 to 2020. Euro Surveill 25(37):1900670","journal-title":"Euro Surveill"},{"issue":"29","key":"3478_CR13","doi-asserted-by":"crossref","first-page":"21192","DOI":"10.2807\/1560-7917.ES2015.20.29.21192","volume":"20","author":"E Severi","year":"2015","unstructured":"Severi\u00a0E, Verhoef\u00a0L, Thornton\u00a0L, Guzman-Herrador\u00a0BR, Faber\u00a0M, Sundqvist\u00a0L et al (2015) Large and prolonged food-borne multistate hepatitis A outbreak in Europe associated with consumption of frozen berries, 2013 to 2014. Euro Surveill 20(29):21192","journal-title":"Euro Surveill"},{"key":"3478_CR14","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.es.2021.26.20.2100432","author":"T Garcia Vilaplana","year":"2021","unstructured":"Garcia Vilaplana\u00a0T, Leeman\u00a0D, Balogun\u00a0K, Ngui\u00a0SL, Phipps\u00a0E, Khan\u00a0WM et\u00a0al (2021to) Hepatitis A outbreak associated with consumption of dates, England and Wales, January 2021 to April 2021. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.es.2021.26.20.2100432","journal-title":"Euro Surveill"},{"issue":"3","key":"3478_CR15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12560-013-9118-0","volume":"5","author":"D M\u00e4de","year":"2013","unstructured":"M\u00e4de\u00a0D, Tr\u00fcbner\u00a0K, Neubert\u00a0E, H\u00f6hne\u00a0M, Johne\u00a0R (2013) Detection and typing of norovirus from frozen strawberries involved in a\u00a0large-scale gastroenteritis outbreak in Germany. Food Environ Virol 5(3):162\u2013168","journal-title":"Food Environ Virol"},{"key":"3478_CR16","volume-title":"Hepatology\u2014a clinical textbook","author":"S Mauss","year":"2020","unstructured":"Mauss\u00a0S, Berg\u00a0T, Rockstroh\u00a0J, Sarrazin\u00a0C, Wedemeyer\u00a0H (2020) Hepatology\u2014a clinical textbook"},{"issue":"34","key":"3478_CR17","first-page":"1","volume":"2020","author":"St\u00e4ndige Impfkommission","year":"2020","unstructured":"St\u00e4ndige Impfkommission (2020) Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut 2020\/2021. Epidemiol Bull 2020(34):1\u201368","journal-title":"Epidemiol Bull"},{"issue":"1","key":"3478_CR18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1186\/s12879-021-06400-4","volume":"21","author":"G Steffen","year":"2021","unstructured":"Steffen\u00a0G, Sperle\u00a0I, Harder\u00a0T, Sarma\u00a0N, Beermann\u00a0S, Thamm\u00a0R et\u00a0al (2021) Hepatitis B vaccination coverage in Germany: systematic review. BMC Infect Dis 21(1):817","journal-title":"BMC Infect Dis"},{"key":"3478_CR19","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1017\/S0950268820000163","volume":"148","author":"M Brandl","year":"2020","unstructured":"Brandl\u00a0M, Schmidt\u00a0A, Marcus\u00a0U, an der Heiden\u00a0M, Dudareva\u00a0S (2020) Are men who have sex with men in Europe protected from hepatitis B? Epidemiol Infect 148:E27","journal-title":"Epidemiol Infect"},{"key":"3478_CR20","doi-asserted-by":"crossref","unstructured":"Cornberg MSL, Protzer U, Niederau C, Tacke F, Berg T et al (2021) S3-Leitlinie der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs-und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/021-011l_S3_Prophylaxe-Diagnostik-Therapie-der-Hepatitis-B-Virusinfektion_2021-07.pdf. Zugegriffen: 19. Okt. 2021","DOI":"10.1055\/a-1498-2512"},{"key":"3478_CR21","unstructured":"Robert Koch-Institut (2016) Hepatitis B und D RKI Ratgeber. https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Merkblaetter\/Ratgeber_HepatitisB.html. Zugegriffen: 19. Okt. 2021"},{"issue":"2","key":"3478_CR22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/vox.12204","volume":"108","author":"M an der Heiden","year":"2015","unstructured":"an der Heiden\u00a0M, Ritter\u00a0S, Hamouda\u00a0O, Offergeld\u00a0R (2015) Estimating the residual risk for HIV, HCV and HBV in different types of platelet concentrates in Germany. Vox Sang 108(2):123\u2013130","journal-title":"Vox Sang"},{"issue":"1","key":"3478_CR23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/INF.0b013e3181ef22d5","volume":"30","author":"W Cai","year":"2011","unstructured":"Cai\u00a0W, Poethko-Muller\u00a0C, Hamouda\u00a0O, Radun\u00a0D (2011) Hepatitis B virus infections among children and adolescents in Germany: migration background as a\u00a0risk factor in a\u00a0low seroprevalence population. Pediatr Infect Dis\u00a0J 30(1):19\u201324","journal-title":"Pediatr Infect Dis J"},{"key":"3478_CR24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijid.2017.10.008","volume":"66","author":"JM Haussig","year":"2018","unstructured":"Haussig\u00a0JM, Nielsen\u00a0S, Gassowski\u00a0M, Bremer\u00a0V, Marcus\u00a0U, Wenz\u00a0B et al (2018) A large proportion of people who inject drugs are susceptible to hepatitis B: results from a\u00a0bio-behavioural study in eight German cities. Int J Infect Dis 66:5\u201313","journal-title":"Int J Infect Dis"},{"issue":"1","key":"3478_CR25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s13104-020-05158-3","volume":"13","author":"I Sperle","year":"2020","unstructured":"Sperle\u00a0I, Nielsen\u00a0S, Gassowski\u00a0M, Naneva\u00a0Z, Perchemlieva\u00a0T, Amato-Gauci\u00a0A et al (2020) Prevalence of hepatitis C in the adult population of Bulgaria: a\u00a0pilot study. BMC Res Notes 13(1):326","journal-title":"BMC Res Notes"},{"key":"3478_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.puhe.2017.07.011","volume":"153","author":"AZ Kortas","year":"2017","unstructured":"Kortas\u00a0AZ, Polenz\u00a0J, von Hayek\u00a0J, Rudiger\u00a0S, Rottbauer\u00a0W, Storr\u00a0U et al (2017) Screening for infectious diseases among asylum seekers newly arrived in Germany in 2015: a\u00a0systematic single-centre analysis. Public Health 153:1\u20138","journal-title":"Public Health"},{"issue":"10","key":"3478_CR27","doi-asserted-by":"crossref","first-page":"17-00176","DOI":"10.2807\/1560-7917.ES.2018.23.10.17-00176","volume":"23","author":"N Ackermann","year":"2018","unstructured":"Ackermann\u00a0N, Marosevic\u00a0D, Hormansdorfer\u00a0S, Eberle\u00a0U, Rieder\u00a0G, Treis\u00a0B et al (2018) Screening for infectious diseases among newly arrived asylum seekers, Bavaria, Germany, 2015. Euro Surveill 23(10):17-00176","journal-title":"Euro Surveill"},{"key":"3478_CR28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3389\/fpubh.2020.00424","volume":"8","author":"I Sperle","year":"2020","unstructured":"Sperle\u00a0I, Steffen\u00a0G, Leendertz\u00a0SA, Sarma\u00a0N, Beermann\u00a0S, Thamm\u00a0R et\u00a0al (2020) Prevalence of hepatitis B, C, and D in Germany: results from a scoping review. Front Public Health 8:424","journal-title":"Front Public Health"},{"key":"3478_CR29","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1017\/S0950268820000242","volume":"148","author":"A von Laer","year":"2020","unstructured":"von Laer\u00a0A, Diercke\u00a0M, der Heiden\u00a0AM, Altmann\u00a0D, Zimmermann\u00a0R, Dudareva\u00a0S (2020) Implications of a\u00a0change in case definition and screening of asylum seekers for hepatitis B surveillance in Germany in 2015 and 2016. Epidemiol Infect 148:e36","journal-title":"Epidemiol Infect"},{"issue":"29","key":"3478_CR30","first-page":"3","volume":"2021","author":"S Burdi","year":"2021","unstructured":"Burdi\u00a0S, Harder\u00a0T, Ullrich\u00a0A, Krings\u00a0A, Sandfort\u00a0M, Dudareva\u00a0S (2021) Virushepatitis B und D im Jahr 2020. Epidemiol Bull 2021(29):3\u201321","journal-title":"Epidemiol Bull"},{"key":"3478_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100103","author":"A Ullrich","year":"2021","unstructured":"Ullrich\u00a0A, Schranz\u00a0M, Rexroth\u00a0U, Hamouda\u00a0O, Schaade\u00a0L, Diercke\u00a0M et al (2021) Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1\u20132016 \u2013 week 32\u20132020. Lancet Reg Health Eur. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100103","journal-title":"Lancet Reg Health Eur"},{"key":"3478_CR32","unstructured":"World Health Organization (2018) Hepatitis D. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-d. Zugegriffen: 28. Juli 2021"},{"issue":"3","key":"3478_CR33","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","volume":"73","author":"AJ Stockdale","year":"2020","unstructured":"Stockdale\u00a0AJ, Kreuels\u00a0B, Henrion\u00a0MYR, Giorgi\u00a0E, Kyomuhangi\u00a0I, de Martel\u00a0C et al (2020) The global prevalence of hepatitis D virus infection: systematic review and meta-analysis. J\u00a0Hepatol 73(3):523\u2013532","journal-title":"J Hepatol"},{"issue":"1","key":"3478_CR34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/epirev\/mxj009","volume":"28","author":"CW Shepard","year":"2006","unstructured":"Shepard\u00a0CW, Simard\u00a0EP, Finelli\u00a0L, Fiore\u00a0AE, Bell\u00a0BP (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28(1):112\u2013125","journal-title":"Epidemiol Rev"},{"issue":"1","key":"3478_CR35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virol.2005.09.033","volume":"344","author":"JM Taylor","year":"2006","unstructured":"Taylor\u00a0JM (2006) Hepatitis delta virus. Virology 344(1):71\u201376","journal-title":"Virology"},{"issue":"12","key":"3478_CR36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s15006-021-0023-4","volume":"163","author":"K Deterding","year":"2021","unstructured":"Deterding\u00a0K, Wedemeyer\u00a0H (2021) New therapeutic options for hepatitis D. MMW Fortschr Med 163(12):62\u201363","journal-title":"MMW Fortschr Med"},{"issue":"9","key":"3478_CR37","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1136\/gutjnl-2020-323888","volume":"70","author":"S Urban","year":"2021","unstructured":"Urban\u00a0S, Neumann-Haefelin\u00a0C, Lampertico\u00a0P (2021) Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease. Gut 70(9):1782\u20131794. https:\/\/doi.org\/10.1136\/gutjnl-2020-323888","journal-title":"Gut"},{"issue":"1","key":"3478_CR38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0031-1281628","volume":"50","author":"C Fischer","year":"2012","unstructured":"Fischer\u00a0C, Mauss\u00a0S, Zehnter\u00a0E, Bokemeyer\u00a0B, Heyne\u00a0R, Huppe\u00a0D (2012) Epidemiology and clinical characteristics of patients with chronic hepatitis B (CHB) in Germany\u2014results of a\u00a0nationwide cross-sectional study. Z\u00a0Gastroenterol 50(1):22\u201329","journal-title":"Z Gastroenterol"},{"issue":"31","key":"3478_CR39","first-page":"299","volume":"2018","author":"Robert Koch-Institut","year":"2018","unstructured":"Robert Koch-Institut (2018) RKI-Ratgeber Hepatitis C. Epidemiol Bull 2018(31):299\u2013307","journal-title":"Epidemiol Bull"},{"key":"3478_CR40","unstructured":"World Health Organization (2019) Hepatitis C. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c. Zugegriffen: 28. Juli 2021"},{"issue":"2","key":"3478_CR41","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","volume":"48","author":"HH Thein","year":"2008","unstructured":"Thein\u00a0HH, Yi\u00a0Q, Dore\u00a0GJ, Krahn\u00a0MD (2008) Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a\u00a0meta-analysis and meta-regression. Hepatology 48(2):418\u2013431","journal-title":"Hepatology"},{"issue":"7","key":"3478_CR42","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag\u00a0HB, Rudolph\u00a0KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132(7):2557\u20132576","journal-title":"Gastroenterology"},{"issue":"11","key":"3478_CR43","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1055\/a-1226-0241","volume":"58","author":"C Sarrazin","year":"2020","unstructured":"Sarrazin\u00a0C, Zimmermann\u00a0T, Berg\u00a0T, Hinrichsen\u00a0H, Mauss\u00a0S, Wedemeyer\u00a0H et al (2020) Addendum: Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion. Z\u00a0Gastroenterol 58(11):1110\u20131131","journal-title":"Z Gastroenterol"},{"issue":"30","key":"3478_CR44","first-page":"275","volume":"2019","author":"Robert Koch-Institut","year":"2019","unstructured":"Robert Koch-Institut (2019) Hepatitis-C-Meldedaten nach IfSG, 2016\u20132018: Auswirkungen der \u00c4nderungen von Falldefinition und Meldepflicht. Epidemiol Bull 2019(30):275","journal-title":"Epidemiol Bull"},{"issue":"Suppl 6","key":"3478_CR45","doi-asserted-by":"crossref","first-page":"e25348","DOI":"10.1002\/jia2.25348","volume":"22","author":"BM Nijmeijer","year":"2019","unstructured":"Nijmeijer\u00a0BM, Koopsen\u00a0J, Schinkel\u00a0J, Prins\u00a0M, Geijtenbeek\u00a0TB (2019) Sexually transmitted hepatitis C virus infections: current trends, and recent advances in understanding the spread in men who have sex with men. J\u00a0Intern AIDS Soc 22(Suppl 6):e25348","journal-title":"J Intern AIDS Soc"},{"issue":"5","key":"3478_CR46","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2019.11.022","volume":"72","author":"E Hoornenborg","year":"2020","unstructured":"Hoornenborg\u00a0E, Coyer\u00a0L, Boyd\u00a0A, Achterbergh\u00a0RCA, Schim van der Loeff\u00a0MF, Bruisten\u00a0S et al (2020) High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis. J\u00a0Hepatol 72(5):855\u2013864","journal-title":"J Hepatol"},{"issue":"6","key":"3478_CR47","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","volume":"59","author":"L Benova","year":"2014","unstructured":"Benova\u00a0L, Mohamoud\u00a0YA, Calvert\u00a0C, Abu-Raddad\u00a0LJ (2014) Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis 59(6):765\u2013773","journal-title":"Clin Infect Dis"},{"issue":"28","key":"3478_CR48","first-page":"3","volume":"2021","author":"E Meyer","year":"2021","unstructured":"Meyer\u00a0E, Steffen\u00a0G, Krings\u00a0A, Ullrich\u00a0A, Kollan\u00a0C, Dudareva\u00a0S et\u00a0al (2021) Zur Situation bei wichtigen Infektionskrankheiten in Deutschland \u2013 Virushepatitis C im Jahr 2020. Epidemiol Bull 2021(28):3\u201319","journal-title":"Epidemiol Bull"},{"issue":"12","key":"3478_CR49","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1055\/a-1291-8518","volume":"58","author":"D H\u00fcppe","year":"2020","unstructured":"H\u00fcppe\u00a0D, Niederau\u00a0C, Serfert\u00a0Y, Hartmann\u00a0H, Wedemeyer\u00a0H (2020) Versorgungsprobleme von Patienten mit chronischer Hepatitis C w\u00e4hrend der COVID-19-Pandemie und der Lockdown-Verordnungen. Z\u00a0Gastroenterol 58(12):1182\u20131185","journal-title":"Z Gastroenterol"},{"issue":"1","key":"3478_CR50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jhep.2017.01.024","volume":"67","author":"R Zimmermann","year":"2017","unstructured":"Zimmermann\u00a0R, Kollan\u00a0C, Ingiliz\u00a0P, Mauss\u00a0S, Schmidt\u00a0D, Bremer\u00a0V (2017) Real-world treatment for chronic hepatitis C infection in Germany: analyses from drug prescription data, 2010\u20132015. J\u00a0Hepatol 67(1):15\u201322","journal-title":"J Hepatol"},{"issue":"5","key":"3478_CR51","doi-asserted-by":"crossref","first-page":"e0250833","DOI":"10.1371\/journal.pone.0250833","volume":"16","author":"P Buggisch","year":"2021","unstructured":"Buggisch\u00a0P, Heiken\u00a0H, Mauss\u00a0S, Weber\u00a0B, Jung\u00a0M\u2011C, G\u00f6rne\u00a0H et al (2021) Barriers to initiation of hepatitis C virus therapy in Germany: a retrospective, case-controlled study. PLoS ONE 16(5):e250833","journal-title":"PLoS ONE"},{"key":"3478_CR52","volume-title":"Abschlussbericht zum Projekt \u201eHIV? Hepatitis? Das CHECK ich!\u201c","author":"M Gerlich","year":"2020","unstructured":"Gerlich\u00a0M, Dichtl\u00a0A, Graf\u00a0N (2020) Abschlussbericht zum Projekt \u201eHIV? Hepatitis? Das CHECK ich!\u201c. Bundeszentrale f\u00fcr gesundheitliche Aufkl\u00e4rung, K\u00f6ln"},{"issue":"9","key":"3478_CR53","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2468-1253(19)30201-8","volume":"4","author":"E Oru","year":"2019","unstructured":"Oru\u00a0E, Verster\u00a0A (2019) Access to hepatitis C care for people who inject drugs and people in prisons. Lancet Gastroenterol Hepatol 4(9):662\u2013663","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"3478_CR54","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/1469-0691.12214","volume":"19","author":"L Christou","year":"2013","unstructured":"Christou\u00a0L, Kosmidou\u00a0M (2013) Hepatitis E virus in the Western world\u2014a pork-related zoonosis. Clin Microbiol Infect 19(7):600\u2013604","journal-title":"Clin Microbiol Infect"},{"issue":"18","key":"3478_CR55","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3748\/wjg.v27.i18.2090","volume":"27","author":"AK Jha","year":"2021","unstructured":"Jha\u00a0AK, Kumar\u00a0G, Dayal\u00a0VM, Ranjan\u00a0A, Suchismita\u00a0A (2021) Neurological manifestations of hepatitis E virus infection: an overview. World J Gastroenterol 27(18):2090\u20132104","journal-title":"World J Gastroenterol"},{"issue":"8","key":"3478_CR56","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","volume":"358","author":"N Kamar","year":"2008","unstructured":"Kamar\u00a0N, Selves\u00a0J, Mansuy\u00a0JM, Ouezzani\u00a0L, P\u00e9ron\u00a0JM, Guitard\u00a0J et al (2008) Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N\u00a0Engl J Med 358(8):811\u2013817","journal-title":"N Engl J Med"},{"key":"3478_CR57","volume-title":"Case-control study on risk factors for acute hepatitis E in Germany, 2012 to 2014","author":"M Faber","year":"2018","unstructured":"Faber\u00a0M, Askar\u00a0M, Stark\u00a0K (2018) Case-control study on risk factors for acute hepatitis E in Germany, 2012 to 2014"},{"issue":"5","key":"3478_CR58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jinf.2019.02.001","volume":"78","author":"AD Tulen","year":"2019","unstructured":"Tulen\u00a0AD, Vennema\u00a0H, van Pelt\u00a0W, Franz\u00a0E, Hofhuis\u00a0A (2019) A case-control study into risk factors for acute hepatitis E in the Netherlands, 2015\u20132017. J\u00a0Infect 78(5):373\u2013381","journal-title":"J Infect"},{"issue":"7","key":"3478_CR59","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1017\/S0950268813002318","volume":"142","author":"B Said","year":"2014","unstructured":"Said\u00a0B, Ijaz\u00a0S, Chand\u00a0MA, Kafatos\u00a0G, Tedder\u00a0R, Morgan\u00a0D (2014) Hepatitis E virus in England and Wales: indigenous infection is associated with the consumption of processed pork products. Epidemiol Infect 142(7):1467\u20131475","journal-title":"Epidemiol Infect"},{"issue":"1\u20132","key":"3478_CR60","first-page":"25","volume":"126","author":"C Baechlein","year":"2013","unstructured":"Baechlein\u00a0C, Seehusen\u00a0F, Nathues\u00a0H, grosse Beilage\u00a0E, Baumg\u00e4rtner\u00a0W, Grummer\u00a0B (2013) Molecular detection of hepatitis E virus in German domestic pigs. Berl Munch Tierarztl Wochenschr 126(1\u20132):25\u201331","journal-title":"Berl Munch Tierarztl Wochenschr"},{"issue":"1","key":"3478_CR61","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcv.2011.06.006","volume":"52","author":"JJ Wenzel","year":"2011","unstructured":"Wenzel\u00a0JJ, Preiss\u00a0J, Schemmerer\u00a0M, Huber\u00a0B, Plentz\u00a0A, Jilg\u00a0W (2011) Detection of hepatitis E virus (HEV) from porcine livers in Southeastern Germany and high sequence homology to human HEV isolates. J\u00a0Clin Virol 52(1):50\u201354","journal-title":"J Clin Virol"},{"key":"3478_CR62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijfoodmicro.2015.09.013","volume":"215","author":"K Szabo","year":"2015","unstructured":"Szabo\u00a0K, Trojnar\u00a0E, Anheyer-Behmenburg\u00a0H, Binder\u00a0A, Schotte\u00a0U, Ellerbroek\u00a0L et al (2015) Detection of hepatitis E virus RNA in raw sausages and liver sausages from retail in Germany using an optimized method. Int J Food Microbiol 215:149\u2013156","journal-title":"Int J Food Microbiol"},{"issue":"11","key":"3478_CR63","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3201\/eid1511.091094","volume":"15","author":"B Said","year":"2009","unstructured":"Said\u00a0B, Ijaz\u00a0S, Kafatos\u00a0G, Booth\u00a0L, Thomas\u00a0HL, Walsh\u00a0A et\u00a0al (2009) Hepatitis E outbreak on cruise ship. Emerg Infect Dis 15(11):1738\u20131744","journal-title":"Emerg Infect Dis"},{"key":"3478_CR64","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1017\/S0950268820001429","volume":"148","author":"H Bi","year":"2020","unstructured":"Bi\u00a0H, Yang\u00a0R, Wu\u00a0C, Xia\u00a0J (2020) Hepatitis E virus and blood transfusion safety. Epidemiol Infect 148:e158","journal-title":"Epidemiol Infect"},{"issue":"5","key":"3478_CR65","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/apt.13938","volume":"45","author":"S Zhang","year":"2017","unstructured":"Zhang\u00a0S, Chen\u00a0C, Peng\u00a0J, Li\u00a0X, Zhang\u00a0D, Yan\u00a0J et\u00a0al (2017) Investigation of underlying comorbidities as risk factors for symptomatic human hepatitis E virus infection. Aliment Pharmacol Ther 45(5):701\u2013713","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"3478_CR66","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/liv.14695","volume":"41","author":"G Buescher","year":"2021","unstructured":"Buescher\u00a0G, Ozga\u00a0AK, Lorenz\u00a0E, Pischke\u00a0S, May\u00a0J, Addo\u00a0MM et al (2021) Hepatitis E seroprevalence and viremia rate in immunocompromised patients: a\u00a0systematic review and meta-analysis. Liver Int 41(3):449\u2013455","journal-title":"Liver Int"},{"issue":"6","key":"3478_CR67","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/jvh.12868","volume":"25","author":"M Faber","year":"2018","unstructured":"Faber\u00a0M, Willrich\u00a0N, Schemmerer\u00a0M, Rauh\u00a0C, Kuhnert\u00a0R, Stark\u00a0K et\u00a0al (2018) Hepatitis E virus seroprevalence, seroincidence and seroreversion in the German adult population. J\u00a0Viral Hepat 25(6):752\u2013758","journal-title":"J Viral Hepat"},{"issue":"2","key":"3478_CR68","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/trf.15058","volume":"59","author":"T Vollmer","year":"2019","unstructured":"Vollmer\u00a0T, Diekmann\u00a0J, Knabbe\u00a0C, Dreier\u00a0J (2019) Hepatitis E virus blood donor NAT screening: as much as possible or as much as needed? Transfusion 59(2):612\u2013622","journal-title":"Transfusion"},{"issue":"1","key":"3478_CR69","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s12879-019-4190-1","volume":"19","author":"J Denner","year":"2019","unstructured":"Denner\u00a0J, Pischke\u00a0S, Steinmann\u00a0E, Blumel\u00a0J, Glebe\u00a0D (2019) Why all blood donations should be tested for hepatitis E virus (HEV). BMC Infect Dis 19(1):541","journal-title":"BMC Infect Dis"},{"issue":"7","key":"3478_CR70","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/liv.14912","volume":"41","author":"TP Velavan","year":"2021","unstructured":"Velavan\u00a0TP, Pallerla\u00a0SR, Johne\u00a0R, Todt\u00a0D, Steinmann\u00a0E, Schemmerer\u00a0M et\u00a0al (2021) Hepatitis E: an update on One Health and clinical medicine. Liver Int 41(7):1462\u20131473","journal-title":"Liver Int"},{"key":"3478_CR71","unstructured":"World Health Organization (2016) Global health sector strategy on viral hepatitis 2016\u20132021. Towards ending viral hepatitis. http:\/\/apps.who.int\/iris\/bitstream\/10665\/246177\/1\/WHO-HIV-2016.06-eng.pdf?ua=1. Zugegriffen: 28. Juli 2021"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-021-03478-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00103-021-03478-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-021-03478-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T20:57:15Z","timestamp":1700081835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00103-021-03478-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["3478"],"URL":"https:\/\/doi.org\/10.1007\/s00103-021-03478-8","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,14]]},"assertion":[{"value":"23 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Dudareva, M.\u00a0Faber, R.\u00a0Zimmermann, C.-T.\u00a0Bock, R.\u00a0Offergeld, G.\u00a0Steffen und J.\u00a0Enkelmann geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}